CrossBridge Bio
Houston
About CrossBridge Bio
CrossBridge Bio operates as a biotechnology company, innovates ADC therapeutics through stable dual linker payload technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $25.0M
- Funding stage: Seed
- Last round: Grant (Nov 2025)
- Website: crossbridgebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/crossbridge-bio-35886 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.